The intercrosses between these strains and the above-summarized models of breast cancer will make it possible to investigate the effect of the myeloid/macrophage-specific FRA-1 ablation on the EMT parameters, metastatic dissemination and response to immune checkpoint inhibitors [133]. The gene discussed is FOSL1; the disease is breast cancer.